Ibrahim, Humood .

HRN: 21-61-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2022
CEFUROXIME 750MG (VIAL)
12/17/2022
12/23/2022
IVT
650mg
Q8
URTI
Waiting Final Action 
12/19/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
12/19/2022
12/25/2022
ORAL
4ml
Q12Hrs
AGE With Mod Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: